{"id":"https://openalex.org/A5016045142","orcid":"https://orcid.org/0009-0003-0037-5283","observed_orcids":["https://orcid.org/0009-0003-0037-5283"],"display_name":"Xiomara Garza Vazquez","raw_author_names":["X V\u00e1zquez","X. Garza Vazquez","Xiomara Garza Vazquez"],"full_name":"Xiomara Garza Vazquez","works_count":5,"cited_by_count":22,"summary_stats":{"2yr_mean_citedness":10.0,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5016045142","orcid":"https://orcid.org/0009-0003-0037-5283","observed_orcids":["https://orcid.org/0009-0003-0037-5283"]},"affiliations":[{"institution":{"id":"https://openalex.org/I180910786","ror":"https://ror.org/030bbe882","display_name":"Universidad de la Rep\u00fablica de Uruguay","country_code":"UY","type":"education","lineage":["https://openalex.org/I180910786"]},"years":[2007]},{"institution":{"id":"https://openalex.org/I181369854","ror":"https://ror.org/00f7hpc57","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I3018771216","ror":"https://ror.org/02jet3w32","display_name":"LMU Klinikum","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},"years":[2026,2024]},{"institution":{"id":"https://openalex.org/I4210088053","ror":"https://ror.org/0030f2a11","display_name":"Universit\u00e4tsklinikum Erlangen","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4210154927","ror":"https://ror.org/04jdthe46","display_name":"Hospital de Cl\u00ednicas","country_code":"UY","type":"healthcare","lineage":["https://openalex.org/I4210154927"]},"years":[2007]},{"institution":{"id":"https://openalex.org/I8204097","ror":"https://ror.org/05591te55","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]},"years":[2026,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I181369854","ror":"https://ror.org/00f7hpc57","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I3018771216","ror":"https://ror.org/02jet3w32","display_name":"LMU Klinikum","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I4210088053","ror":"https://ror.org/0030f2a11","display_name":"Universit\u00e4tsklinikum Erlangen","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I8204097","ror":"https://ror.org/05591te55","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":4,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":4,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","count":2,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","count":1,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","value":3.47e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":1.57e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","value":9.8e-06,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9736499190330505},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6820999979972839},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.6654999852180481},{"id":"2779915274","wikidata":"https://www.wikidata.org/wiki/Q1115882","display_name":"Extracorporeal","score":0.5586000084877014},{"id":"188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","score":0.5203999876976013}],"counts_by_year":[{"year":2007,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":10},{"year":2026,"works_count":3,"oa_works_count":2,"cited_by_count":9}],"display_name_alternatives":["X V\u00e1zquez","X. Garza Vazquez","Xiomara Garza Vazquez"],"block_key":"x garza vazquez","works_api_url":"https://api.openalex.org/works?filter=author.id:A5016045142","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5016045142","updated_date":"2026-11-16T12:53:42","created_date":"2016-06-24T00:00:00"}
